First Trust Nasdaq Pharmaceuticals ETF (NASDAQ: FTXH)

Dernières nouvelles pour First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

First Trust Nasdaq Pharmaceuticals ETF

Healthcare

The Fund will normally invest at least 90 percent of its net assets (including investment borrowings) in the securities that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index is owned and is developed, maintained and sponsored by Nasdaq, Inc. (the Index Provider). The Index Provider may, from time to time, exercise reasonable discretion as it deems appropriate in order to ensure Index integrity.

Pfizer, Inc.

Abbvie Inc.

Johnson & Johnson

Bristol-Myers Squibb Co.

Merck & Company, Inc.

United Therapeutic

Amgen Inc.

Nvaesrtex Pharmaceuticals Inc

Regeneron Parmaceuticals Inc.

Gilead Sciences Inc

Cardinal Health Inc.

Jazz Pharmaceuticals Plc

Eli Lilly & Co.

Zoetis  Inc .

Biogen Inc. Com

Viatris

BMO Capital analyst Kostas Biliouris downgrades Verve Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>) from Outperform to Market Perform and lowers the price target from $20 to $13.5.

News

Downgrades

Price Target

Analyst Ratings

VERV

BMO Capital Downgrades Verve Therapeutics to Market Perform, Lowers Price Target to $13.5

Shares of Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) rallied during Friday&#8217;s trading session after the company reported <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46143305/nike-stock-is-climbing-higher-friday-whats-going-on">upbeat fiscal fourth-quarter results on Thursday</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
BofA Securities On Nike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59947083803ad3000162314b/lorraine-hutchinson">Analyst Lorraine Hutchinson</a> reiterated a Buy rating, while raising the price target from $80 to $84.
Nike's sales are poised to improve, and the company could return to growth in the back half of the year, Hutchinson said in a note. Management indicated that Nike witnessed the "worst sales and margin pressure from its turnaround strategy" in the fourth quarter, she added.
The company guided to a gross margin contraction in the fiscal first quarter, which reflects "tariff headwind, ongoing DTC clearance and product and channel mix headwinds," the analyst wrote. Gross margins could improve in the second quarter and there is "upside to our estimates as Nike laps significant promos in both DTC and wholesale with new innovation," she further stated.
Goldman Sachs On Nike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/60eef53155f722000105d101/brooke-roach">Analyst Brooke Roach</a> maintained a Buy rating, while lifting the price target from $72 to $81.
Nike reported an earnings beat for the latest quarter and provided "better-than-feared forward commentary against a backdrop of low investor expectations," Roach said.
The company continues to face strong earnings pressure and its recovery could take time, especially in China, the analyst stated. She added, however, that management believes that the worst is over and indicated "several greenshoots within its performance portfolio."
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Needham On Nike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846ee56ee7bf6000154d12e/tom-nikic">Analyst Tom Nikic</a> reaffirmed a Buy rating, while raising the price target from $56 to $78.
Nike's fourth-quarter results were better than feared, and gave hope that the worst was over, Nikic said. The company is now re-focusing on performance products to drive improvement, he added.
Nike has also recognized the importance of its key wholesale partners, the analyst stated. While margins continue to be under pressure, this is expected to moderate in the back half of the year, he further mentioned.
Telsey Advisory Group On Nike
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5f9ab74825a7ef0001015b59/cristina-fernandez">Analyst Cristina Fernández</a> reaffirmed a Market Perform rating and price target of $70.
Nike&#8217;s quarterly results had "several encouraging data points," Fernández said. The company reported sales and earnings ahead of expectations, while the gross margin contraction was as anticipated, she added.
The running category, where Nike has innovated the most, grew by high single digits globally, the analyst stated. "Nike noted its wholesale order book is positive for the holiday season, partially due to door expansion," she further wrote.
NKE Price Action: Shares of Nike were up 15.5% to $72.24 at the time of publication on Friday.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46111337/micron-ceo-cautions-ai-boom-may-not-be-fully-sustainable-flags-tariff-driven-demand-pull-in"> Nike Faces $1 Billion Trump Tariff Blow, Plans &#8216;Surgical&#8217; Price Hikes Starting Fall 2025 To Offset Impact</a></li>
</ul>
Photo: Shutterstock

Reiteration

Nike Beats The Street And Says The Worst Is Over

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains Glacier Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBCI#NYSE">GBCI</a>) with a Market Perform and raises the price target from $50 to $52.

GBCI

Keefe, Bruyette & Woods Maintains Market Perform on Glacier Bancorp, Raises Price Target to $52

WIIM

James Hardie Industries shares are trading higher after William Blair initiated coverage with an Outperform rating.

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/06/2025-06-27_08h54_20.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">More Fuel Coming For Hot AI Trade</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-pce-inflation-hot-ai-trade-spy-mc-06272025">click here</a> for an enlarged chart of SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) which represents the benchmark stock market index S&amp;P 500 (SPX).
Note the following:
<ul class="wp-block-list">
<li>The chart shows SPY has hit a new all time high breaking out above zone 1.&nbsp; Zone 1 was previously resistance and will become support if the breakout is sustained.</li>
<li>Prudent investors will be watching the volume and the velocity of the move today.</li>
<li>RSI on the chart shows that the stock market is slightly overbought and still has room to run.</li>
<li>There is more fuel for the hot AI trade.&nbsp; There is a report that President Trump is planning executive orders to boost AI in the U.S. &nbsp; President Trump previously ordered the production of an AI Action Plan to make "America the world capital in artificial intelligence."&nbsp; The plan is due by July 23, which the White House may declare AI Action Day.</li>
<li>Adding to the extreme bullishness in the stock market is a statement from President Trump on trade deals, "Everybody wants to make a deal and have a part of it… we just signed with China yesterday. We are having some great deals. We have one coming up, maybe with India. A very big one. Where we're going to open up India. In the China deal, we are starting to open up China." 
<ul class="wp-block-list">
<li>The U.S. and China have finalized details of a trade deal framework.&nbsp; China has agreed to loosen rare earth mineral export restrictions in return for the U.S. removing countermeasures.</li>
<li>Indian trade negotiators arrived in the U.S. today to continue talks.</li>
<li>Commerce Secretary Lutnick indicated trade agreements are close with ten major trading partners.</li>
<li>The end of the 90 day pause on reciprocal tariffs is approaching.&nbsp; Adding to bullishness is an expectation in the stock market that it is a soft deadline and negotiations are underway in good faith.</li>
</ul>
</li>
<li>PCE is the Fed&#8217;s favorite inflation gauge.&nbsp; Inflation came slightly hotter than expected.&nbsp; Here are the details: 
<ul class="wp-block-list">
<li>Headline PCE came at 0.1% vs. 0.1% consensus.</li>
<li>Core PCE came at 0.2% vs. 0.1% consensus.</li>
</ul>
</li>
<li>The U.S. economy is 70% consumer based.&nbsp; For this reason, prudent investors pay attention to personal income and personal spending.&nbsp; Personal spending and personal income dropped. &nbsp; Here are the details: 
<ul class="wp-block-list">
<li>Personal spending came at -0.1% vs. 0.2% consensus.</li>
<li>Personal income came at -0.4% vs. 0.4% consensus.</li>
</ul>
</li>
<li>University of Michigan Consumer Sentiment was released at 10am ET.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), and NVIDIA Corp (NVDA).
In the early trade, money flows are neutral in Microsoft Corp (MSFT).
In the early trade, money flows are negative in Tesla Inc TSLA).
In the early trade, money flows are positive in S&amp;P 500 ETF (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">Arora Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  Our proprietary Protection Band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Equities

Government

Market Summary

Broad U.S. Equity ETFs

Opinion

Markets

Tech

Trading Ideas

Core PCE Hotter; More Fuel For Hot AI Trade - Trump Says 'A Very Big One' Is Ahead

<h3>Gainers</h3>
<ul>
<li>WF Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFF#NASDAQ">WFF</a>) stock moved upwards by 340.1% to $29.22 during Friday's regular session. The company's market cap stands at $167.2 million. </li>
<li>New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) stock moved upwards by 25.16% to $1.89. The company's market cap stands at $47.3 million. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) stock rose 23.32% to $3.12. The market value of their outstanding shares is at $17.4 million. </li>
<li>KULR Technology Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares increased by 23.29% to $6.4. The company's market cap stands at $198.2 million. </li>
<li>JVSPAC Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSA#NASDAQ">JVSA</a>) stock increased by 21.67% to $11.49. The company's market cap stands at $72.5 million. </li>
<li>MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) shares rose 14.6% to $15.27. The company's market cap stands at $1.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) stock fell 20.9% to $0.14 during Friday's regular session. The market value of their outstanding shares is at $2.6 million. </li>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock declined by 9.01% to $1.01. The market value of their outstanding shares is at $85.1 million. </li>
<li>Voyager Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYG#NYSE">VOYG</a>) shares decreased by 8.89% to $44.6. The market value of their outstanding shares is at $2.8 billion. </li>
<li>Odyssey Marine Explr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMEX#NASDAQ">OMEX</a>) stock fell 8.39% to $1.19. The market value of their outstanding shares is at $40.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

HOVR

JVSA

KULR

OMEX

VOYG

YGMZ

10 Industrials Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Sonder Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOND#NASDAQ">SOND</a>) shares moved upwards by 23.4% to $1.98 during Friday's regular session. The market value of their outstanding shares is at $17.6 million. </li>
<li>High Roller Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ROLR#AMEX">ROLR</a>) shares moved upwards by 21.85% to $3.29. The market value of their outstanding shares is at $22.7 million. </li>
<li>Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) shares rose 15.61% to $72.31. The company's market cap stands at $92.5 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares moved upwards by 13.42% to $1.44. The company's market cap stands at $38.2 million. </li>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) stock moved upwards by 12.02% to $0.56. The market value of their outstanding shares is at $4.3 million. </li>
<li>Pitanium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTNM#NASDAQ">PTNM</a>) shares rose 11.07% to $7.72. The company's market cap stands at $158.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Perfect Moment (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PMNT#AMEX">PMNT</a>) shares declined by 42.0% to $0.25 during Friday's regular session. </li>
<li>Epsium Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPSM#NASDAQ">EPSM</a>) shares decreased by 25.9% to $16.2. The company's market cap stands at $293.7 million. </li>
<li>Genius Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) stock fell 19.14% to $0.93. The market value of their outstanding shares is at $82.2 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) stock declined by 18.0% to $4.01. The market value of their outstanding shares is at $995.4 million. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares declined by 17.57% to $0.63. </li>
<li>Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) stock decreased by 17.51% to $0.59. The company's market cap stands at $32.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EPSM

LOBO

LVWR

MULN

NDLS

PMNT

PTNM

ROLR

SOND

TLYS

12 Consumer Discretionary Stocks Moving In Friday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) shares rose 46.4% to $5.12 during Friday's regular session. The market value of their outstanding shares is at $250.4 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares increased by 43.97% to $11.36. The company's market cap stands at $22.7 million. </li>
<li>Citius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) shares moved upwards by 30.88% to $1.74. The market value of their outstanding shares is at $14.4 million. </li>
<li>I-MAB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) shares increased by 27.72% to $2.58. The company's market cap stands at $163.3 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) stock moved upwards by 27.52% to $1.14. The company's market cap stands at $111.2 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock rose 27.39% to $6.65. The company's market cap stands at $2.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ontrak (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTRK#NASDAQ">OTRK</a>) stock decreased by 44.1% to $0.54 during Friday's regular session. The market value of their outstanding shares is at $4.1 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares fell 39.82% to $9.99. The company's market cap stands at $431.8 million. </li>
<li>Achieve Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHV#NASDAQ">ACHV</a>) stock declined by 37.32% to $2.2. The company's market cap stands at $121.7 million. </li>
<li>Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) stock fell 34.54% to $1.27. The company's market cap stands at $3.9 million. The company's, Q4 earnings came out yesterday. </li>
<li>Lyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) stock decreased by 29.83% to $9.39. The company's market cap stands at $17.7 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) shares fell 29.08% to $0.33. The company's market cap stands at $7.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACHV

ADIL

AEMD

CTOR

CTXR

EYEN

GCTK

IMAB

LIMN

LYRA

OTRK

12 Health Care Stocks Moving In Friday's Intraday Session

Macro Economic Events

Econ #s

Economics

U.S. Baker Hughes Oil Rig Count -6 To 432; U.S. Baker Hughes NatGas Rig Count -2 To 109; U.S. Baker Hughes Total Rig Count 546 Vs 554 Prior

<h3>Gainers</h3>
<ul>
<li>Locafy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) stock increased by 250.6% to $8.94 during Friday's regular session. The company's market cap stands at $3.2 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) shares moved upwards by 66.07% to $3.82. The company's market cap stands at $1.0 million. </li>
<li>Youxin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) stock moved upwards by 31.72% to $4.9. The company's market cap stands at $124.8 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares rose 19.73% to $5.4. The market value of their outstanding shares is at $2.7 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock rose 19.66% to $16.27. The market value of their outstanding shares is at $23.8 million. </li>
<li>CXApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXAI#NASDAQ">CXAI</a>) shares moved upwards by 17.98% to $1.07. The company's market cap stands at $18.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares fell 40.8% to $0.33 during Friday's regular session. The company's market cap stands at $59.0 million. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) stock fell 18.01% to $2.33. The company's market cap stands at $5.1 million. </li>
<li>3 E Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASK#NASDAQ">MASK</a>) shares fell 15.33% to $2.21. The market value of their outstanding shares is at $29.3 million. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) stock fell 13.89% to $0.42. The company's market cap stands at $75.7 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) stock declined by 12.04% to $10.09. The company's market cap stands at $191.3 million. </li>
<li>Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) shares declined by 10.08% to $2.46. The market value of their outstanding shares is at $277.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASTI

AUUD

BZAI

CXAI

LCFY

MASK

SVRE

WOLF

YAAS

12 Information Technology Stocks Moving In Friday's Intraday Session

WF Holding Shares Halted On Circuit Breaker To The Upside, Stock Now Up 340.1%

Truist Securities analyst Joseph Civello maintains Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Buy and raises the price target from $73 to $85.

Truist Securities Maintains Buy on Nike, Raises Price Target to $85

LULU

CNBC Halftime Report Final Trades: Rockwell Automation, Lululemon Athletica, Meta Platforms, KKR & Co.

Financial giants have made a conspicuous bearish move on Booking Holdings. Our analysis of options history for Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) revealed 47 unusual trades.
Delving into the details, we found 27% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $993,182, and 33 were calls, valued at $2,489,583.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $4450.0 to $8300.0 for Booking Holdings over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Booking Holdings's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Booking Holdings's whale trades within a strike price range from $4450.0 to $8300.0 in the last 30 days. 
<h3>Booking Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751043652_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$35.0</td>
<td>$32.0</td>
<td>$35.0</td>
<td>$5900.00</td>
<td>$448.0K</td>
<td align="right">15</td>
<td align="right">130</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$309.9</td>
<td>$297.5</td>
<td>$297.5</td>
<td>$5400.00</td>
<td>$207.9K</td>
<td align="right">41</td>
<td align="right">0</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/27/25</td>
<td>$202.6</td>
<td>$176.0</td>
<td>$190.8</td>
<td>$5510.00</td>
<td>$190.8K</td>
<td align="right">50</td>
<td align="right">38</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$307.0</td>
<td>$306.9</td>
<td>$307.0</td>
<td>$5650.00</td>
<td>$153.5K</td>
<td align="right">8</td>
<td align="right">0</td>
</tr>
<tr>
<td>BKNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/01/25</td>
<td>$208.3</td>
<td>$183.3</td>
<td>$197.66</td>
<td>$5670.00</td>
<td>$138.3K</td>
<td align="right">0</td>
<td align="right">7</td>
</tr>
</tbody>
</table>

<h3>About Booking Holdings</h3>
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, Rentalcars.com, Kayak, and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.
Following our analysis of the options activities associated with Booking Holdings, we pivot to a closer look at the company's own performance.
<h3>Where Is Booking Holdings Standing Right Now?</h3>
<ul>
<li>With a trading volume of 113,907, the price of BKNG is up by 1.6%, reaching $5685.78.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 34 days from now.</li>
</ul>
<h3>What The Experts Say On Booking Holdings</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $5910.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Booking Holdings, which currently sits at a price target of $6000. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Neutral rating for Booking Holdings, targeting a price of $5820. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Booking Holdings options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

BKNG

Booking Holdings Unusual Options Activity For June 27

Investors with a lot of money to spend have taken a bullish stance on Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with LRCX, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 20 uncommon options trades for Lam Research.
This isn't normal.
The overall sentiment of these big-money traders is split between 55% bullish and 45%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $327,780, and 16 are calls, for a total amount of $986,243.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $120.0 for Lam Research, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Lam Research options trades today is 1270.18 with a total volume of 1,743.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Lam Research's big money trades within a strike price range of $60.0 to $120.0 over the last 30 days.
<h3>Lam Research Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751043647_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$19.75</td>
<td>$19.7</td>
<td>$19.7</td>
<td>$100.00</td>
<td>$277.8K</td>
<td>4.1K</td>
<td align="right">141</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$38.05</td>
<td>$37.5</td>
<td>$37.83</td>
<td>$60.00</td>
<td>$189.1K</td>
<td>449</td>
<td align="right">50</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$5.15</td>
<td>$5.1</td>
<td>$5.15</td>
<td>$95.00</td>
<td>$154.5K</td>
<td>349</td>
<td align="right">302</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.93</td>
<td>$1.93</td>
<td>$1.93</td>
<td>$70.00</td>
<td>$96.5K</td>
<td>1.9K</td>
<td align="right">500</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$5.9</td>
<td>$5.8</td>
<td>$5.9</td>
<td>$120.00</td>
<td>$88.5K</td>
<td>736</td>
<td align="right">150</td>
</tr>
</tbody>
</table>

<h3>About Lam Research</h3>
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
In light of the recent options history for Lam Research, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Lam Research Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 2,746,753, the LRCX's price is up by 0.14%, now at $96.98. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 33 days.</li>
</ul>
<h3>Professional Analyst Ratings for Lam Research</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $113.33.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from B. Riley Securities keeps a Buy rating on Lam Research with a target price of $115. 
&#x2A; An analyst from Oppenheimer persists with their Outperform rating on Lam Research, maintaining a target price of $110. 
&#x2A; An analyst from Cantor Fitzgerald persists with their Overweight rating on Lam Research, maintaining a target price of $115. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Lam Research with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

LRCX

Decoding Lam Research's Options Activity: What's the Big Picture?

Whales with a lot of money to spend have taken a noticeably bullish stance on PepsiCo.
Looking at options history for PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) we detected 30 trades.
If we consider the specifics of each trade, it is accurate to state that 56% of the investors opened trades with bullish expectations and 26% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $252,870 and 25, calls, for a total amount of $1,195,576.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $110.0 to $270.0 for PepsiCo during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for PepsiCo's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across PepsiCo's significant trades, within a strike price range of $110.0 to $270.0, over the past month.
<h3>PepsiCo Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751043642_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$7.4</td>
<td>$7.3</td>
<td>$7.3</td>
<td>$150.00</td>
<td>$102.2K</td>
<td>1.6K</td>
<td align="right">482</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$2.12</td>
<td>$1.99</td>
<td>$1.99</td>
<td>$145.00</td>
<td>$93.9K</td>
<td>2.5K</td>
<td align="right">0</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$9.2</td>
<td>$9.0</td>
<td>$9.17</td>
<td>$130.00</td>
<td>$91.9K</td>
<td>2.4K</td>
<td align="right">107</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$3.85</td>
<td>$3.8</td>
<td>$3.84</td>
<td>$145.00</td>
<td>$76.9K</td>
<td>2.7K</td>
<td align="right">334</td>
</tr>
<tr>
<td>PEP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$7.3</td>
<td>$7.2</td>
<td>$7.2</td>
<td>$150.00</td>
<td>$72.0K</td>
<td>1.6K</td>
<td align="right">100</td>
</tr>
</tbody>
</table>

<h3>About PepsiCo</h3>
PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US, but uses bottlers overseas for beverages. International markets made up 40% of both total sales and operating profits in 2024.
After a thorough review of the options trading surrounding PepsiCo, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is PepsiCo Standing Right Now?</h3>
<ul>
<li>With a volume of 5,258,407, the price of PEP is up 1.81% at $130.54. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 20 days.</li>
</ul>
<h3>What Analysts Are Saying About PepsiCo</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $148.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from RBC Capital downgraded its action to Sector Perform with a price target of $148. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for PepsiCo, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

A Closer Look at PepsiCo's Options Market Dynamics

Truist Securities analyst Michael Ciarmoli maintains Kratos Defense &amp; Security (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) with a Buy and raises the price target from $38 to $52.

KTOS

Truist Securities Maintains Buy on Kratos Defense & Security, Raises Price Target to $52

Zimmer Biomet Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) short percent of float has risen 16.61% since its last report. The company recently reported that it has 6.42 million shares sold short, which is 3.72% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.65 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Zimmer Biomet Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751043628_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Zimmer Biomet Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Zimmer Biomet Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Zimmer Biomet Holdings's peer group average for short interest as a percentage of float is 5.20%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into Zimmer Biomet Holdings's Recent Short Interest

When a parent wants to support their adult children, it can be difficult to know where to draw the line — especially when housing is involved. On a <a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-how-much-should-i-charge-my-child-in-rent">recent episode</a> of the "Women &amp; Money" podcast, personal finance expert Suze Orman responded to a listener named Keila, a divorced mom with two young adult children. One lives with her already; the other is asking to move back in — with her boyfriend.
But <a href="https://www.benzinga.com/personal-finance/25/05/45606627/suze-orman-says-she-still-pays-700-monthly-on-her-amex-but-its-made-her-705000-in-interest">Orman</a> didn't hold back. Her advice? Don't do it.
Don't Miss:
<ul class="wp-block-list">
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
</ul>
<h2 class="wp-block-heading">The Backstory: One Mom, Two Kids, and a Tight Budget</h2>
Keila earns about $92,000 a year and still owes $60,000 on her mortgage. She also has a $25,000 home equity loan — which she took out for home repairs — no emergency fund, and is financially helping both of her children. Her 22-year-old daughter makes $30,000 annually and lives with her boyfriend, who earns around $20,000 a year from seasonal construction work.
The young couple is facing <a href="https://www.benzinga.com/real-estate/24/06/39274689/amid-rising-costs-financial-strain-becomes-americas-chief-anxiety">financial strain</a> and wants to move in with Keila "for a period of time" to save up for a house. Keila asked Orman for guidance on what to charge them in rent — hoping to strike a balance between helping them and teaching financial responsibility.
<h2 class="wp-block-heading">"People First" Means You First, Says Orman</h2>
Orman pointed out something critical: Keila appears stable on paper, but she's stretched thin. Taking out a home equity loan for repairs signals that she doesn't have cash reserves, which puts her at risk if anything goes wrong — like a job loss or unexpected expense.
"You have to think about yourself before you continue to think about your kids," Orman said. "When I say ‘people first,' I mean you, Mama."
Trending: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a>
<h2 class="wp-block-heading">Why Orman Objects to the Boyfriend Moving In</h2>
Orman questioned the boyfriend's role in the plan. While Keila's daughter is working and in school, her boyfriend is not in school and has irregular income. "Is that a boyfriend that has ambition?" Orman asked.
She also warned against assuming they'll be able to buy a house anytime soon. With their current financial situation, "they can no more afford a home than the man in the moon," Orman said.
<h2 class="wp-block-heading">If You Say Yes, Here's What Orman Recommends</h2>
If Keila does allow them to move in, Orman laid out specific guardrails:
<ul class="wp-block-list">
<li>Charge $700 per month in rent plus any increase in utility or grocery costs</li>
<li>Require a monthly contribution to a savings account, and review it regularly</li>
<li>Create a written agreement outlining house rules, quiet hours, cleaning duties, and a move-out timeline</li>
<li>Use the boyfriend's skills – like home repairs – as part of their rent contribution</li>
</ul>
"I&#8217;m just saying that&#8217;s what I would be doing to teach them responsibility," Orman said. "I would not make it easy on them."
See Also: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Now Raising at $3/Share</a>
<h2 class="wp-block-heading">Setting Boundaries Isn't Just Financial — It's Emotional</h2>
Orman also raised a key point: How will Keila's 20-year-old son — who already lives with her — feel about sharing the space with his sister and her boyfriend? That discussion needs to happen first, Orman said.
Ultimately, Orman's message was clear: A parent's job isn't to solve every problem — it's to prepare their kids to stand on their own. And in this case, saying no might be the most loving — and <a href="https://www.benzinga.com/25/05/45555404/at-some-point-you-have-to-be-financially-responsible-says-luxury-watch-buyer-as-market-loses-50-million-shoppers">financially responsible</a> — thing Keila can do.
Read Next: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?

Personal Finance

Her Daughter and Boyfriend Asked to Move In – Suze Orman Told Her She Should Say No

In the current market session, American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) share price is at $11.34, after a 1.89% spike. Moreover, over the past month, the stock fell by 0.61%, but in the past year, went up by 2.72%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1751043625_0.png" alt="Past Year Chart" />

<h3>How Does American Airlines Group P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
American Airlines Group has a lower P/E than the aggregate P/E of 12.72 of the Passenger Airlines industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751043625_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: American Airlines Group

Comments

First Trust Nasdaq Pharmaceuticals ETF

Actualités

Dernières nouvelles pour First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL